We are now Vedaly!
To reflect the expanded scope of our services and platform, OmicsChart is now called Vedaly.
To reflect the expanded scope of our services and platform, OmicsChart is now called Vedaly.
OmicsChart CEO, Tanya Aneichyk, presented our cutting-edge omics data solution at the WMF - We Make Future 2024 conference in Italy.
OmicsChart joined the Affiliated Companies network at the Milner Therapeutics Institute, Cambridge University, UK.
OmicsChart successfully completed PharmStars accelerator program, culminating in a Showcase Event in Boston, USA.
OmicsChart has successfully graduated from the prestigious Techstars accelerator program, marking a milestone in its recognition for the pioneering utilization of omics data within the field of oncology research.
OmicsChart is thrilled to be selected for Techstars Berlin 2023 Deep Tech accelerator, emphasizing its commitment to advancing precision oncology through innovative technology.
Revisiting an excellent blog post by our founder and CEO Dr Tatsiana Aneichyk on commercialization in bioinformatics research.
OmicsChart publicly launches PREON, its flagship cancer data and biomarker discovery platform.
OmicsChart received Merck Healthcare Speed Grant to investigate molecular biomarkers of HRD in cancer patients.
OmicsChart was selected as one of the top runners for Merck KGaA 2022 Research Grant.
Start?Zuschuss is a grant by Bavarian State Ministry for Economic Affairs, Regional Development and Energy to support digitalization.